Biopharmaceutical and Drug Development

About

The Biopharmaceutical and Drug Development team at Atheln specializes in enhancing biopharma products through downstream process optimization, CMC (Chemistry, Manufacturing, and Controls) strategies, bioassay development, analytical development, and cell line and upstream process development. They focus on scaling up manufacturing processes, qualifying and validating bioassays, and optimizing single-use bioreactors to ensure efficient and reliable product development and commercialization.